A 2nd-Generation Scalable Synthesis of the HIV-1 Entry Inhibitor CJF-III-288 Enabled by Photoredox Catalysis
Abstract
The development and optimization of a 2nd-Generation process synthesis for the human immunodeficiency virus-1 entry inhibitor CJF-III-288 bis-trufloroacetate salt 1 is reported. The route eliminates the use of noble metals, decreases the step count nearly by half, and increases the overall yield tenfold.
Please wait while we load your content...